{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T02:47:21Z","timestamp":1775098041028,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Peking Union Medical College Hospital Talent Cultivation Program Category D","award":["UHB12595"],"award-info":[{"award-number":["UHB12595"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401026"],"award-info":[{"award-number":["82401026"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences","award":["2017-I2M-1-001"],"award-info":[{"award-number":["2017-I2M-1-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04595-7","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T13:34:22Z","timestamp":1775050462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Genetic Profile of Chinese Familial Hypocalciuric Hypercalcemia Type 1 (FHH1): A Retrospective Study"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3659-9372","authenticated-orcid":false,"given":"Liyuan","family":"Kou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6572-1827","authenticated-orcid":false,"given":"An","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7179-0044","authenticated-orcid":false,"given":"Min","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0547-2595","authenticated-orcid":false,"given":"Yue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6687-1464","authenticated-orcid":false,"given":"Yingyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1438-0942","authenticated-orcid":false,"given":"Yiyang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4434-3462","authenticated-orcid":false,"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7270-4902","authenticated-orcid":false,"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-5536","authenticated-orcid":false,"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0395-8789","authenticated-orcid":false,"given":"Ou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2759-5177","authenticated-orcid":false,"given":"Xiaoping","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"4595_CR1","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1007\/s40618-024-02366-7","volume":"47","author":"F Cetani","year":"2024","unstructured":"F. Cetani, E. Dinoi, L. Pierotti, E. Pardi, Familial states of primary hyperparathyroidism: an update. J. Endocrinol. Invest. 47, 2157\u20132176 (2024). https:\/\/doi.org\/10.1007\/s40618-024-02366-7","journal-title":"J. Endocrinol. Invest."},{"key":"4595_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s002230001201","volume":"68","author":"J Hinnie","year":"2001","unstructured":"J. Hinnie, E. Bell, E. McKillop, S. Gallacher, The prevalence of familial hypocalciuric hypercalcemia. Calcif Tissue Int. 68, 216\u2013218 (2001). https:\/\/doi.org\/10.1007\/s002230001201","journal-title":"Calcif Tissue Int."},{"key":"4595_CR3","doi-asserted-by":"publisher","unstructured":"P. Glendenning, B.G. Stuckey, (2002) The estimated prevalence of familial hypocalciuric hypercalcemia (FHH). Calcif Tissue Int 70: 512; author reply 512\u2013513.https:\/\/doi.org\/10.1007\/s00223-001-0040-3","DOI":"10.1007\/s00223-001-0040-3"},{"key":"4595_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.beem.2018.05.004","volume":"32","author":"JY Lee","year":"2018","unstructured":"J.Y. Lee, D.M. Shoback, Familial hypocalciuric hypercalcemia and related disorders. Best Pract. Res. Clin. Endocrinol. Metab. 32, 609\u2013619 (2018). https:\/\/doi.org\/10.1016\/j.beem.2018.05.004","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"4595_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ajhg.2020.04.006","volume":"106","author":"R Dershem","year":"2020","unstructured":"R. Dershem, C.M. Gorvin, R.P.R. Metpally, S. Krishnamurthy, D.T. Smelser et al., Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population. Am. J. Hum. Genet. 106, 734\u2013747 (2020). https:\/\/doi.org\/10.1016\/j.ajhg.2020.04.006","journal-title":"Am. J. Hum. Genet."},{"key":"4595_CR6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2174\/138920109787847475","volume":"10","author":"G Vezzoli","year":"2009","unstructured":"G. Vezzoli, L. Soldati, G. Gambaro, Roles of calcium-sensing receptor (CaSR) in renal mineral ion transport. Curr. Pharm. Biotechnol. 10, 302\u2013310 (2009). https:\/\/doi.org\/10.2174\/138920109787847475","journal-title":"Curr. Pharm. Biotechnol."},{"key":"4595_CR7","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1172\/jci118987","volume":"98","author":"SH Pearce","year":"1996","unstructured":"S.H. Pearce, M. Bai, S.J. Quinn, O. Kifor, E.M. Brown, R.V. Thakker, Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells. J. Clin. Invest. 98, 1860\u20131866 (1996). https:\/\/doi.org\/10.1172\/jci118987","journal-title":"J. Clin. Invest."},{"key":"4595_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1210\/jcem.86.1.7149","volume":"86","author":"TS Jap","year":"2001","unstructured":"T.S. Jap, Y.C. Wu, S.F. Jenq, G.S. Won, A novel mutation in the calcium-sensing receptor gene in a Chinese subject with persistent hypercalcemia and hypocalciuria. J. Clin. Endocrinol. Metab. 86, 13\u201315 (2001). https:\/\/doi.org\/10.1210\/jcem.86.1.7149","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4595_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cccn.2005.04.026","volume":"360","author":"CW Lam","year":"2005","unstructured":"C.W. Lam, K.F. Lee, A.O. Chan, P.M. Poon, T.Y. Law, S.F. Tong, Novel missense mutation in the CASR gene in a Chinese family with familial hypocalciuric hypercalcemia. Clin. Chim. Acta. 360, 167\u2013172 (2005). https:\/\/doi.org\/10.1016\/j.cccn.2005.04.026","journal-title":"Clin. Chim. Acta"},{"key":"4595_CR10","doi-asserted-by":"publisher","first-page":"17001","DOI":"10.1038\/boneres.2017.1","volume":"5","author":"B Wu","year":"2017","unstructured":"B. Wu, O. Wang, Y. Jiang, M. Li, X. Xing, W. Xia, Atypical skeletal manifestations of rickets in a familial hypocalciuric hypercalcemia patient. Bone Res. 5, 17001 (2017). https:\/\/doi.org\/10.1038\/boneres.2017.1","journal-title":"Bone Res."},{"key":"4595_CR11","doi-asserted-by":"publisher","unstructured":"F.C.K. Wong, W.S. Wong, J.S.S. Kwok, T.K.C. Tsui, K.P. Lau et al., (2019) A Hong Kong Chinese kindred with familial hypocalciuric hypercalcaemia caused by AP2S1 mutation. F1000Res 8: 1612.https:\/\/doi.org\/10.12688\/f1000research.20344.1","DOI":"10.12688\/f1000research.20344.1"},{"key":"4595_CR12","doi-asserted-by":"publisher","first-page":"e21940","DOI":"10.1097\/MD.0000000000021940","volume":"99","author":"F Wang","year":"2020","unstructured":"F. Wang, J. Hu, C. Mei, X. Lin, L. Zhang, Familial hypocalciuric hypercalcemia caused by homozygous CaSR gene mutation: A case report of a family. Med. (Baltim). 99, e21940 (2020). https:\/\/doi.org\/10.1097\/md.0000000000021940","journal-title":"Med. (Baltim)."},{"key":"4595_CR13","doi-asserted-by":"publisher","first-page":"e26443","DOI":"10.1097\/MD.0000000000026443","volume":"100","author":"Y Ji","year":"2021","unstructured":"Y. Ji, C. Kang, J. Chen, L. Zhang, Identification of p.Arg205Cys in CASR in an autosomal dominant hypocalcaemia type 1 pedigree: A case report. Med. (Baltim). 100, e26443 (2021). https:\/\/doi.org\/10.1097\/md.0000000000026443","journal-title":"Med. (Baltim)."},{"key":"4595_CR14","doi-asserted-by":"publisher","first-page":"1291160","DOI":"10.3389\/fendo.2024.1291160","volume":"15","author":"CM Lin","year":"2024","unstructured":"C.M. Lin, Y.X. Ding, S.M. Huang, Y.C. Chen, H.J. Lee et al., Identification and characterization of a novel CASR mutation causing familial hypocalciuric hypercalcemia. Front. Endocrinol. (Lausanne). 15, 1291160 (2024). https:\/\/doi.org\/10.3389\/fendo.2024.1291160","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"4595_CR15","first-page":"1075","volume":"56","author":"YH Chou","year":"1995","unstructured":"Y.H. Chou, M.R. Pollak, M.L. Brandi, G. Toss, H. Arnqvist et al., Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. Am. J. Hum. Genet. 56, 1075\u20131079 (1995)","journal-title":"Am. J. Hum. Genet."},{"key":"4595_CR16","first-page":"226","volume":"14","author":"RC Ma","year":"2008","unstructured":"R.C. Ma, C.W. Lam, W.Y. So, P.C. Tong, C. Cockram, C.C. Chow, A novel CASR gene mutation in an octogenarian with asymptomatic hypercalcaemia. Hong Kong Med. J. 14, 226\u2013228 (2008)","journal-title":"Hong Kong Med. J."},{"key":"4595_CR17","doi-asserted-by":"publisher","first-page":"e868","DOI":"10.1210\/clinem\/dgae659","volume":"110","author":"Y Liu","year":"2025","unstructured":"Y. Liu, N. Sinha Gregory, P. Andreopoulou, S. Kashyap, N. Cusano, Approach to the Patient: Normocalcemic Primary Hyperparathyroidism. J. Clin. Endocrinol. Metab. 110, e868 (2025). https:\/\/doi.org\/10.1210\/clinem\/dgae659","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4595_CR18","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/jbmr.4883","volume":"38","author":"A Song","year":"2023","unstructured":"A. Song, Y. Yang, Y. Jiang, M. Nie, Y. Jiang et al., Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single-center study. J. Bone Min. Res. 38, 1322\u20131333 (2023). https:\/\/doi.org\/10.1002\/jbmr.4883","journal-title":"J. Bone Min. Res."},{"key":"4595_CR19","doi-asserted-by":"publisher","unstructured":"J.P. Bilezikian, A.A. Khan, S.J. Silverberg, G.E. Fuleihan, C. Marcocci et al., (2022) Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. J Bone Miner Res 37: 2293\u20132314.https:\/\/doi.org\/10.1002\/jbmr.4677","DOI":"10.1002\/jbmr.4677"},{"key":"4595_CR20","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1056\/NEJMcp032200","volume":"350","author":"JP Bilezikian","year":"2004","unstructured":"J.P. Bilezikian, S.J. Silverberg, Clinical practice. Asymptomatic primary hyperparathyroidism. N Engl. J. Med. 350, 1746\u20131751 (2004). https:\/\/doi.org\/10.1056\/NEJMcp032200","journal-title":"N Engl. J. Med."},{"key":"4595_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"S. Richards, N. Aziz, S. Bale, D. Bick, S. Das et al., Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015). https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet. Med."},{"key":"4595_CR22","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2022.18331","volume":"328","author":"MD Walker","year":"2022","unstructured":"M.D. Walker, E. Shane, Hypercalcemia: A Review. Jama. 328, 1624\u20131636 (2022). https:\/\/doi.org\/10.1001\/jama.2022.18331","journal-title":"Jama"},{"key":"4595_CR23","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4158\/ep09346.Or","volume":"17","author":"J Norman","year":"2011","unstructured":"J. Norman, A. Goodman, D. Politz, Calcium, parathyroid hormone, and vitamin D in patients with primary hyperparathyroidism: normograms developed from 10,000 cases. Endocr. Pract. 17, 384\u2013394 (2011). https:\/\/doi.org\/10.4158\/ep09346.Or","journal-title":"Endocr. Pract."},{"key":"4595_CR24","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1210\/jc.2015-3442","volume":"101","author":"R Vargas-Poussou","year":"2016","unstructured":"R. Vargas-Poussou, L. Mansour-Hendili, S. Baron, J.P. Bertocchio, C. Travers et al., Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences. J. Clin. Endocrinol. Metab. 101, 2185\u20132195 (2016). https:\/\/doi.org\/10.1210\/jc.2015-3442","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4595_CR25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1210\/jcem-72-3-541","volume":"72","author":"AF Firek","year":"1991","unstructured":"A.F. Firek, P.C. Kao, H. 3 Heath rd, Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 72, 541\u2013546 (1991). https:\/\/doi.org\/10.1210\/jcem-72-3-541","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4595_CR26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s12020-023-03560-y","volume":"83","author":"Q Asla","year":"2024","unstructured":"Q. Asla, H. Sard\u00e0, N. Segu\u00ed, G. Mart\u00ednez de Pinillos, I. Mazarico-Altisent et al., Clinical and outcome comparison of genetically positive vs. negative patients in a large cohort of suspected familial hypocalciuric hypercalcemia. Endocrine. 83, 747\u2013756 (2024). https:\/\/doi.org\/10.1007\/s12020-023-03560-y","journal-title":"Endocrine"},{"key":"4595_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.surg.2019.06.043","volume":"167","author":"TK Pandian","year":"2020","unstructured":"T.K. Pandian, C.C. Lubitz, S.H. Bird, L.E. Kuo, A.E. Stephen, Normocalcemic hyperparathyroidism: A Collaborative Endocrine Surgery Quality Improvement Program analysis. Surgery. 167, 168\u2013172 (2020). https:\/\/doi.org\/10.1016\/j.surg.2019.06.043","journal-title":"Surgery"},{"key":"4595_CR28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1210\/jc.2012-2914","volume":"98","author":"L Zhao","year":"2013","unstructured":"L. Zhao, J.M. Liu, X.Y. He, H.Y. Zhao, L.H. Sun et al., The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center. J. Clin. Endocrinol. Metab. 98, 721\u2013728 (2013). https:\/\/doi.org\/10.1210\/jc.2012-2914","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4595_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00774-020-01142-w","volume":"39","author":"AK Arya","year":"2021","unstructured":"A.K. Arya, P. Kumari, S.K. Bhadada, K. Agrawal, P. Singh et al., Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: Data from PHPT registry. J. Bone Min. Metab. 39, 253\u2013259 (2021). https:\/\/doi.org\/10.1007\/s00774-020-01142-w","journal-title":"J. Bone Min. Metab."},{"key":"4595_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/jbmr.3339","volume":"33","author":"SJ Marx","year":"2018","unstructured":"S.J. Marx, Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism. J. Bone Min. Res. 33, 27\u201331 (2018). https:\/\/doi.org\/10.1002\/jbmr.3339","journal-title":"J. Bone Min. Res."},{"key":"4595_CR31","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1365-2265.2009.03557.x","volume":"71","author":"SE Christensen","year":"2009","unstructured":"S.E. Christensen, P.H. Nissen, P. Vestergaard, L. Heickendorff, L. Rejnmark et al., Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism. Clin. Endocrinol. (Oxf). 71, 798\u2013807 (2009). https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03557.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"4595_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00223-011-9517-x","volume":"89","author":"T Isaksen","year":"2011","unstructured":"T. Isaksen, C.S. Nielsen, S.E. Christensen, P.H. Nissen, L. Heickendorff, L. Mosekilde, Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study. Calcif Tissue Int. 89, 285\u2013294 (2011). https:\/\/doi.org\/10.1007\/s00223-011-9517-x","journal-title":"Calcif Tissue Int."},{"key":"4595_CR33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.4158\/ep11272.Ra","volume":"18","author":"LS Eldeiry","year":"2012","unstructured":"L.S. Eldeiry, D.T. Ruan, E.M. Brown, J.L. Gaglia, J.R. Garber, Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications. Endocr. Pract. 18, 412\u2013417 (2012). https:\/\/doi.org\/10.4158\/ep11272.Ra","journal-title":"Endocr. Pract."},{"key":"4595_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/cen.14211","volume":"93","author":"C Mouly","year":"2020","unstructured":"C. Mouly, R. Vargas-Poussou, A. Lienhardt, C. Silve, M. Hureaux et al., Clinical characteristics of familial hypocalciuric hypercalcaemia type 1: A multicentre study of 77 adult patients. Clin. Endocrinol. (Oxf). 93, 248\u2013260 (2020). https:\/\/doi.org\/10.1111\/cen.14211","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"4595_CR35","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1210\/jc.2017-02773","volume":"103","author":"JP Bertocchio","year":"2018","unstructured":"J.P. Bertocchio, M. Tafflet, E. Koumakis, G. Maruani, R. Vargas-Poussou et al., Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia. J. Clin. Endocrinol. Metab. 103, 2534\u20132542 (2018). https:\/\/doi.org\/10.1210\/jc.2017-02773","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4595_CR36","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1210\/jc.2014-3708","volume":"100","author":"C Cipriani","year":"2015","unstructured":"C. Cipriani, F. Biamonte, A.G. Costa, C. Zhang, P. Biondi et al., Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. J. Clin. Endocrinol. Metab. 100, 1309\u20131315 (2015). https:\/\/doi.org\/10.1210\/jc.2014-3708","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4595_CR37","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1681\/asn.2008111195","volume":"20","author":"KY Renkema","year":"2009","unstructured":"K.Y. Renkema, A. Velic, H.B. Dijkman, S. Verkaart, van der A.W. Kemp et al., The calcium-sensing receptor promotes urinary acidification to prevent nephrolithiasis. J. Am. Soc. Nephrol. 20, 1705\u20131713 (2009). https:\/\/doi.org\/10.1681\/asn.2008111195","journal-title":"J. Am. Soc. Nephrol."},{"key":"4595_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.surg.2021.04.055","volume":"171","author":"SR Li","year":"2022","unstructured":"S.R. Li, K.L. McCoy, H.E. Levitt, M.L. Kelley, S.E. Carty, L. Yip, Is routine 24-hour urine calcium measurement useful during the evaluation of primary hyperparathyroidism? Surgery. 171, 17\u201322 (2022). https:\/\/doi.org\/10.1016\/j.surg.2021.04.055","journal-title":"Surgery"},{"key":"4595_CR39","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/postgradmedj-2020-137718","volume":"97","author":"MF Arshad","year":"2021","unstructured":"M.F. Arshad, J. McAllister, A. Merchant, E. Rab, J. Cook et al., Urinary calcium indices in primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcaemia (FHH): which test performs best? Postgrad. Med. J. 97, 577\u2013582 (2021). https:\/\/doi.org\/10.1136\/postgradmedj-2020-137718","journal-title":"Postgrad. Med. J."},{"key":"4595_CR40","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1210\/jcem.85.5.6477","volume":"85","author":"T Carling","year":"2000","unstructured":"T. Carling, E. Szabo, M. Bai, P. Ridefelt, G. Westin et al., Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J. Clin. Endocrinol. Metab. 85, 2042\u20132047 (2000). https:\/\/doi.org\/10.1210\/jcem.85.5.6477","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4595_CR41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1365-2265.1990.tb03881.x","volume":"33","author":"JL Pasieka","year":"1990","unstructured":"J.L. Pasieka, M.A. Andersen, D.A. Hanley, Familial benign hypercalcaemia: hypercalciuria and hypocalciuria in affected members of a small kindred. Clin. Endocrinol. (Oxf). 33, 429\u2013433 (1990). https:\/\/doi.org\/10.1111\/j.1365-2265.1990.tb03881.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"4595_CR42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.4158\/ep12284.Ra","volume":"19","author":"MC Shinall Jr","year":"2013","unstructured":"M.C. Jr. Shinall, K.M. Dahir, J.T. Broome, Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism. Endocr. Pract. 19, 697\u2013702 (2013). https:\/\/doi.org\/10.4158\/ep12284.Ra","journal-title":"Endocr. Pract."},{"key":"4595_CR43","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1365-2265.2008.03259.x","volume":"69","author":"SE Christensen","year":"2008","unstructured":"S.E. Christensen, P.H. Nissen, P. Vestergaard, L. Heickendorff, K. Brixen, L. Mosekilde, Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Clin. Endocrinol. (Oxf). 69, 713\u2013720 (2008). https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03259.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"4595_CR44","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1124\/pr.119.018531","volume":"72","author":"K Leach","year":"2020","unstructured":"K. Leach, F.M. Hannan, T.M. Josephs, A.N. Keller, T.C. M\u00f8ller et al., International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function. Pharmacol. Rev. 72, 558\u2013604 (2020). https:\/\/doi.org\/10.1124\/pr.119.018531","journal-title":"Pharmacol. Rev."},{"key":"4595_CR45","doi-asserted-by":"publisher","unstructured":"J. H\u00f6ppner, K. Sinningen, A. Raimann, B. Obermayer-Pietsch, C. Grasemann, (2022) Disorders of the Calcium Sensing Signaling Pathway: From Familial Hypocalciuric Hypercalcemia (FHH) to Life Threatening Conditions in Infancy. J Clin Med 11.https:\/\/doi.org\/10.3390\/jcm11092595","DOI":"10.3390\/jcm11092595"},{"key":"4595_CR46","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1210\/endrev\/bnaf010","volume":"46","author":"A Roumpou","year":"2025","unstructured":"A. Roumpou, A. Palermo, S. Tournis, V. Hasenmajer, J.L. Pasieka et al., Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes. Endocr. Rev. 46, 576\u2013620 (2025). https:\/\/doi.org\/10.1210\/endrev\/bnaf010","journal-title":"Endocr. Rev."},{"key":"4595_CR47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.berh.2007.11.006","volume":"22","author":"OI Egbuna","year":"2008","unstructured":"O.I. Egbuna, E.M. Brown, Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract. Res. Clin. Rheumatol. 22, 129\u2013148 (2008). https:\/\/doi.org\/10.1016\/j.berh.2007.11.006","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"4595_CR48","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.13662","author":"Y Geng","year":"2016","unstructured":"Y. Geng, L. Mosyak, I. Kurinov, H. Zuo, E. Sturchler et al., Structural mechanism of ligand activation in human calcium-sensing receptor. Elife. (2016). https:\/\/doi.org\/10.7554\/eLife.13662","journal-title":"Elife"},{"key":"4595_CR49","doi-asserted-by":"publisher","first-page":"e1600241","DOI":"10.1126\/sciadv.1600241","volume":"2","author":"C Zhang","year":"2016","unstructured":"C. Zhang, T. Zhang, J. Zou, C.L. Miller, R. Gorkhali et al., Structural basis for regulation of human calcium-sensing receptor by magnesium ions and an unexpected tryptophan derivative co-agonist. Sci. Adv. 2, e1600241 (2016). https:\/\/doi.org\/10.1126\/sciadv.1600241","journal-title":"Sci. Adv."},{"key":"4595_CR50","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/hmg\/dds105","volume":"21","author":"FM Hannan","year":"2012","unstructured":"F.M. Hannan, M.A. Nesbit, C. Zhang, T. Cranston, A.J. Curley et al., Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. Hum. Mol. Genet. 21, 2768\u20132778 (2012). https:\/\/doi.org\/10.1093\/hmg\/dds105","journal-title":"Hum. Mol. Genet."},{"key":"4595_CR51","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1210\/clinem\/dgae735","volume":"110","author":"W Du","year":"2025","unstructured":"W. Du, I.M. Boisen, S.N. Rahman, N.N. Poulsen, J.M. Mathiesen et al., Heterogeneous Origins of Calcium Homeostasis Disorders Arising From 5 Heterozygous Calcium-Sensing Receptor Variants. J. Clin. Endocrinol. Metab. 110, 1865\u20131880 (2025). https:\/\/doi.org\/10.1210\/clinem\/dgae735","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4595_CR52","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1515\/jpem-2018-0307","volume":"32","author":"TE Forman","year":"2019","unstructured":"T.E. Forman, A.K. Niemi, P. Prahalad, R.Z. Shi, L.M. Nally, Cinacalcet therapy in an infant with an R185Q calcium-sensing receptor mutation causing hyperparathyroidism: a case report and review of the literature. J. Pediatr. Endocrinol. Metab. 32, 305\u2013310 (2019). https:\/\/doi.org\/10.1515\/jpem-2018-0307","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"4595_CR53","doi-asserted-by":"publisher","first-page":"101097","DOI":"10.1016\/j.bonr.2021.101097","volume":"15","author":"M Aubert-Mucca","year":"2021","unstructured":"M. Aubert-Mucca, C. Dubucs, M. Groussolles, J. Vial, Le E. Guillou et al., Prenatal features and neonatal management of severe hyperparathyroidism caused by the heterozygous inactivating calcium-sensing receptor variant, Arg185Gln: A case report and review of the literature. Bone Rep. 15, 101097 (2021). https:\/\/doi.org\/10.1016\/j.bonr.2021.101097","journal-title":"Bone Rep."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04595-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04595-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04595-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T02:03:20Z","timestamp":1775095400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04595-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4595"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04595-7","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors affirm that human research participants provided informed consent for.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"127"}}